HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melkersson-Rosenthal syndrome: a form of pseudoangioedema.

AbstractBACKGROUND:
Melkersson-Rosenthal syndrome is an unusual cause of facial swelling that can be confused with angioedema.
OBJECTIVE:
To describe a young woman with facial swelling initially considered to be angioedema.
METHODS:
A biopsy specimen of the eyelid demonstrated findings consistent with Melkersson-Rosenthal syndrome.
RESULTS:
After reviewing the differential diagnosis of pseudoangioedema, a presumptive diagnosis of Melkersson-Rosenthal syndrome was made. The patient was successfully treated with infliximab for Melkersson-Rosenthal syndrome. Owing to medication adverse effects, infliximab treatment was discontinued. Treatment was then continued with adalimumab, with good effect and without adverse events.
CONCLUSIONS:
We report the case of a patient with Melkersson-Rosenthal syndrome presenting as angioedema. Furthermore, we report the first successful treatment of Melkersson-Rosenthal syndrome with adalimumab.
AuthorsCharlene Kakimoto, Chad Sparks, Andrew A White
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (Ann Allergy Asthma Immunol) Vol. 99 Issue 2 Pg. 185-9 (Aug 2007) ISSN: 1081-1206 [Print] United States
PMID17718107 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Adalimumab
Topics
  • Adalimumab
  • Adult
  • Angioedema (diagnosis)
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Biopsy
  • Diagnosis, Differential
  • Eyelids (pathology)
  • Female
  • Humans
  • Melkersson-Rosenthal Syndrome (diagnosis, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: